PARP
PARP(多聚ADP核糖聚合酶)
Poly (ADP-ribose) polymerases (PARPs) is a large family of proteins with a conserved catalytic domain that catalyze an immediate DNA-damage-dependent post-translational modification of histones and other nuclear proteins leading to the survival of injured proliferating cells. So far, a total number of 18 human PARP proteins encoded by different genes have been identified, including PARP-1 to PARP-4, PARP-5a, PARP-5b, PARP-5c and PARP-6 to PARP-16. The general structural of PARP proteins has been revealed through the extensive study of the founding family member PARP-1, which is characterized by the presence of four functional domains, including a DNA-binding domain, a caspase-cleaved domain, an automodification domain and a catalytic domain.
PARP 相关产品(118)
- GC34071Pamiparib (BGB-290)CAS: 1446261-44-4纯度: >99.50%
Pamiparib (BGB-290)是一种强效口服的聚腺苷二磷酸核糖聚合酶(PARP)抑制剂,对PARP-1和PARP-2的IC 50 值分别为1.3nM和0.9nM。
- GC34120Niraparib R-enantiomer (MK 4827 (R-enantiomer))CAS: 1038915-58-0纯度: >99.50%
Niraparib R-enantiomer (MK-4827 R-enantiomer) 是一种出色的 PARP1 抑制剂,IC50 为 2.4 nM。
- GC351505,7,4'-TrimethoxyflavoneCAS: 5631-70-9纯度: >99.50%
4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein.
- GC35550BRCA1-IN-2CAS: 1622262-55-8纯度: >98.00%
BRCA1-IN-2 (compound 15) 是具有细胞渗透性的 BRCA1 蛋白-蛋白相互作用 (PPI) 的抑制剂,IC50 值 0.31 μM,Kd 值为 0.3 μM, BRCA1-IN-2 通过阻断 BRCA1 (BRCT)2/ 蛋白质相互作用而具有抗肿瘤活性。
- GC36855Paris saponin VIICAS: 68124-04-9纯度: >98.00% / >98.50%
Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway.
- GC37728Talazoparib tosylateCAS: 1373431-65-2纯度: >99.50%
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。
- GC39302PARP14 inhibitor H10CAS: 2084811-68-5纯度: >98.00%
PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC19505 | RK-287107 | 2171386-10-8 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC19542 | GeA-69 | 2143475-98-1 | >99.50% | |
GeA-69 是一种多聚腺苷二磷酸核糖聚合酶 14 (PARP14) 的选择性变构抑制剂,靶向大结构域 2 (MD2),Kd 值为 2.1 µM。 GeA-69 参与 DNA 损伤修复机制并阻止 PARP14 MD2 募集到激光诱导的 DNA 损伤部位。 | ||||
| GC32793 | Rucaparib Camsylate | 1859053-21-6 | >99.50% | |
A PARP1 inhibitor | ||||
| GC33223 | BRCA1-IN-1 | 1622262-74-1 | - | |
BRCA1-IN-1是一种新型的小分子BRCA1抑制剂,IC50和Ki分别为0.53μM和0.71μM。 | ||||
| GC33358 | WD2000-012547 | 283172-68-9 | - | |
WD2000-012547是一种选择性的PARP-1抑制剂,pKi为8.221。 | ||||
| GC34071 | Pamiparib (BGB-290) | 1446261-44-4 | >99.50% | |
Pamiparib (BGB-290)是一种强效口服的聚腺苷二磷酸核糖聚合酶(PARP)抑制剂,对PARP-1和PARP-2的IC 50 值分别为1.3nM和0.9nM。 | ||||
| GC34120 | Niraparib R-enantiomer (MK 4827 (R-enantiomer)) | 1038915-58-0 | >99.50% | |
Niraparib R-enantiomer (MK-4827 R-enantiomer) 是一种出色的 PARP1 抑制剂,IC50 为 2.4 nM。 | ||||
| GC34195 | K-756 | 130017-40-2 | >99.00% | |
K-756是一种直接的选择性tankyrase(TNKS)抑制剂,抑制TNKS1和TNKS2的ADP-核糖基化活性,IC50分别为31和36nM。 | ||||
| GC35150 | 5,7,4'-Trimethoxyflavone | 5631-70-9 | >99.50% | |
4',5,7-Trimethoxyflavone (5,7,4'-Trimethoxyflavone, TMF) is a flavonoid isolated from Kaempferia parviflora (KP) that induces apoptosis. 4',5,7-Trimethoxyflavone increases sub-G1 phase, DNA fragmentation, annexin-V/PI staining and Bax/Bcl-xL ratio, activates caspase-3 and degrades poly (ADP-ribose) polymerase (PARP) protein. | ||||
| GC35547 | BR102375 | 2366255-59-4 | - | |
BR102375 是一种用于治疗 2 型糖尿病的 non-TZD (噻唑烷二酮类) PPAR γ 完全激动剂, 其 EC50 值和 Amax比率值分别为 0.28 μM 和 98%。 | ||||
| GC35550 | BRCA1-IN-2 | 1622262-55-8 | >98.00% | |
BRCA1-IN-2 (compound 15) 是具有细胞渗透性的 BRCA1 蛋白-蛋白相互作用 (PPI) 的抑制剂,IC50 值 0.31 μM,Kd 值为 0.3 μM, BRCA1-IN-2 通过阻断 BRCA1 (BRCT)2/ 蛋白质相互作用而具有抗肿瘤活性。 | ||||
| GC36751 | NMS-P515 | 1262395-13-0 | - | |
NMS-P515 是有效的、口服有效的、立体定向的PARP-1 的抑制剂,Kd 值为16 nM,IC50 值为 27 nM (Hela 细胞中)。有抗肿瘤活性。 | ||||
| GC36855 | Paris saponin VII | 68124-04-9 | >98.00% / >98.50% | |
Chonglou Saponin VII (Dioscinin, Polyphyllin-VII, Paris saponin-VII), a kind of steroidal saponins from Chonglou (Rhizoma Paridis Chonglou), inhibits EMT and reduces the invasion of ovarian cancer cells via the GSK-3β/β-catenin signaling pathway. | ||||
| GC37728 | Talazoparib tosylate | 1373431-65-2 | >99.50% | |
Talazoparib tosylate(BMN 673ts)是一种有效的具有口服活性的PARP1/2抑制剂,是Talazoparib的甲苯磺酸盐形式。Talazoparib抑制PARP1的IC 50 值为0.57nM。 | ||||
| GC37735 | Tankyrase-IN-2 | 1588870-36-3 | >99.50% | |
A TNKS1/2 inhibitor | ||||
| GC39302 | PARP14 inhibitor H10 | 2084811-68-5 | >98.00% | |
PARP14 inhibitor H10 (化合物 H10) 是针对 PARP14 的选择性抑制剂 (IC50=490 nM),是其他 PARP 的抑制剂 (约为 PARP1 的 24 倍)。PARP14 抑制剂 H10 诱导 caspase-3/7 介导的细胞凋亡 (apoptosis)。 | ||||
| GC40468 | 1,5-Isoquinolinediol | 5154-02-9 | >99.00% | |
An inhibitor of poly(ADP-ribose) polymerases | ||||
| GC45772 | 6(5H)-Phenanthridinone | 1015-89-0 | >98.00% | |
An inhibitor of PARP1 and 2 | ||||
| GC45808 | OUL35 | 6336-34-1 | >99.00% | |
An inhibitor of PARP10 | ||||
| GC46900 | AZ9482 | 1825345-33-2 | >98.00% | |
A PARP inhibitor | ||||
| GC47055 | CAY10749 | 2337386-47-5 | >98.00% | |
A dual inhibitor of PARP and PI3K | ||||
| GC47056 | CAY10753 | - | >98.00% | |
A TNKS2 inhibitor | ||||
| GC47693 | m-Methoxybenzamide | 5813-86-5 | >98.00% | |
A PARP inhibitor | ||||
| GC50506 | Fluorescein-NAD+ | - | - | |
荧光素-NAD+ 是放射性标记的 NAD 的替代品,也是 ADP 核糖基化的底物。 | ||||
